The emerging approach of the medication represents a major advance in the care of diabetes mellitus type 2. Unlike existing therapies, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide367173.blog2news.com/42598947/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment